[Cardiovascular complications in COVID-19 patients admitted to intensive care units in Chilean hospitals].

Background: Patients with a cardiovascular (CV) history may be at greater risk of becoming ill and die due to SARS-CoV-2.

Aim: To assess the incidence of CV complications in COVID-19 patients, the type of complication, and their association with CV history.

Material And Methods: The clinical course of 1,314 patients with COVID-19 admitted consecutively to critical care units of 10 Chilean hospitals was registered between April and August of 2020.

CYP2C192 Polymorphism in Chilean Patients with In-Stent Restenosis Development and Controls.

Clopidogrel is an antiplatelet drug especially used in patients undergoing percutaneous coronary interventions (PCI). Polymorphisms within can result in important interindividual variations regarding therapeutic efficacy. Therefore, we aimed to evaluate the impact of the CYP2C192 variant (rs4244285) on in-stent restenosis occurrence in Chilean patients who underwent PCI and received clopidogrel.